Do androgens modulate luteinizing hormone secretion in women?;¿Modulan los andrógenos la secreción de hormona luteinizante en mujeres?

Revista Medica de Chile

Volumn 125, Issue 6, 1997, Pages 710-718

  Sir P, Teresa ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b Inst de Invest Materno Infantil   (Chile)

Author keywords

Androgens; Estrogen antagonists; Estrogens; Luteinizing hormone

Indexed keywords

ANDROGEN; ESTROGEN; GONADOTROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ARTICLE; BLOOD; FEMALE; HUMAN; HYPERANDROGENISM; PHYSIOLOGY;

ANDROGENS; ESTROGENS; FEMALE; GONADOTROPINS; HUMANS; HYPERANDROGENISM; LUTEINIZING HORMONE; TESTOSTERONE;

EID: 0031151016     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. BURGER CW, KORSEN T, VAN KESSEL H, VAN DOP PA, CARON FJ, SCHOEMAKER J. Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non PCOD secondary amenorrhoea. J Clin Endocrinol Metab 1985; 61: 1126-32.
2. SHOHAM Z, JACOBS HS, INSLER V. Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril 1993; 59: 1153-61.
3. KAZER RR, KESSEL B, YEN SS. Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1987; 65: 233-6.
4. APTER D, BÜTZOW T, LAUGHLIN GA, YEN SSC. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: Relevance to the developmental phase of polycystic ovarian syndrome. J Clin Endocrinol Metab 1994; 79: 119-25.
5. WALDSTREICHER J, SANTORO NF, HALL JE, FILICORI M, CROWLEY WF JR. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: Indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 1988; 66: 165-72.
6. REBAR R, JUDD HL, YEN SSC, ET AL. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 1976; 57: 1320-9.
7. ADASHI EY, HSUEH AJ, YEN SSC. Insulin enhancement of luteinising hormone and follicle stimulating hormone release by cultured pituitary cells. Endocrinology 1981; 108: 1441-9.
8. YEN SSC. Chronic anovulation due to CNS-hypothalamic-pituitary dysfunction. In: Yen SSC, Jaffe RB (eds). Reproductive Endocrinology. Philadelphia: WB Saunders Company, 1991, pp: 631-5.
9. DE VANE GW, CZEKALA NM, JUDD HL, ET AL. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol 1975; 121: 496-500.
10. LOBO RA, GRANGER L, GOEBELSMANN U, ET AL. Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCOD. J Clin Endocrinol Metab 1981; 52: 156-8.
11. MESSINIS IE, TEMPLETON A. Attenuation of gonadotrophin release and reserve in superovulated women by gonadotrophin surge attenuating factor. Clin Endocrinol 1991; 34: 259-63.
12. FOWLER PA, TEMPLETON A, MESSINI IE. The ovarian modulation of gonadotrophin releasing hormone-induced luteinizing hormone secretion in women. Human Reproduction 1993; 8 (Suppl 2): 112-6.
13. KNOBIL E, PLANT TM, WILDT L, BELCHETZ PE, MARSHALL G. Control of the Rhesus monkey menstrual cycle: permissive role of hypothalamic gonadotropin releasing hormone (GnRH). Science 1980; 207: 1371-3.
14. LEYENDECKER G, WILDT L, HANSMANN M. Pregnancies following chronic intermittent (pulsatile) administration of GnRH by means of a portable pump ("Zyklomat"). A new approach to the treatment of infertility in hypothalamic amenorreha. J Clin Endocr Metab 1980; 51: 1214-6.
15. SIR T, DEVOTO L, KOHEN P, ALBA F, NAVARRO V. Inducción de ovulación con factor liberador de gonadotrofina (GnRH) en Amenorrea Hipotalámica. Ciclo concepcional. Rev Chil Ginecol Obstet 1987; 9: 25-8.
16. JAFFE RB, KEYE WR JR. Augmentation of pituitary responsiveness to gonadotropin-releasing hormone in women. J Clin Endocrinol Metab 1974; 39: 850-5.
17. ERICKSON GF. Normal ovarian function. Clin Obstet Gynecol 1978; 21: 31-5.
18. HSUEH AJW, BILLIG H, TSAFRIRI A. Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 1994; 15: 707-24.
19. HOMBURG R, ARMAR NA, ESHEL A, ADAMS J, JACOBS HS. Influence of serum luteinising hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br Med J 1988; 297: 1024-6.
20. REGAN L, OWEN EJ, JACOBS HS. Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet 1990; 336: 1141-4.
21. EHRMANN DA, BARNES RB, ROSENFIELD RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocrine Rev 1995; 16: 322-53.
22. YEN SSC, VELA P, RANKIN J. Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab 1970; 30: 435-42.
23. CHANG RJ, MANFDEL FP, LU JK, JUDD HL. Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease. J Clin Endocrinol Metab 1982; 54: 490-4.
24. DUNAIF A, LONGCOPE C, CANICK J, BADGER T, CROWLEY WF JR. The effects of the aromatase inhibitor delta-1-testolactone on gonadotropin release and steroid metabolism in polycystic ovarian disease. J Chin Endocrinol Metab 1985; 60: 773-80.
25. SANTEN RJ. Is aromatization of testosterone to estradiol required for inhibition of luteinizing hormone secretion in men? J Chin Invest 1975; 56: 1555-63.
26. MARYNICK SP, LORIEAUX DL, SHERING RJ, PITA JC, LIPSETT MB. Evidence that testosterone can supress pituitary gonadotropin secretion independently of peripheral aromatization. J Clin Endocrinol Metab 1979; 49: 396-8.
27. URBAN RJ, DAVIS MR, ROGAL AD, JOHNSON ML, VELDHUIS JD. Acute androgen receptor blockade increases luteinizing hormone secretory activity in men. J Chin Endocrinol Metab 1988; 67: 1149-55.
28. VELDHUIS JD, KING JC, URBAN RJ, ROGAL AD, EVANO WS, KOLP LA, JOHNSON ML. Operating characteristics of the male hypothalamo-pituitary-gonadal axis: Pulsatile release of testosterone and follicle stimulating hormone and their temporal coupling with luteinizing hormone. J Clin Endocrinol Metab 1987; 65: 929-41.
29. KNOBIL E. The neuroendocrine control of the menstrual cycle. Recent Prog Hormone Res 1980; 36: 53-88.
30. KNOBIL E. The neuroendocrine control of ovulation. Human Reproduction 1988; 3: 469-72.
31. ROPERS JF, QUIGLEY ME, YEN SSC. Endogenous opiates modulate pulsatile luteinizing hormone release in human. J Chin Endocrinol Metab 1981; 52: 583-5.
32. VELDHUIS JD, ROGAL AD. Role of androgenous opiates in the expression of negative feed back actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man. J Chin Invest 1984; 74: 47-55.
33. PETRIE EC, MATSUMOTO AM, BREMMER WJ. Modulation of luteininzing hormone pulse amplitude by the frequency-of-luteinizing-hormone-releasing-hormone stimulation and by testosterone in castrated, hypothalamic-lesioned male rats. Biol Reprod 1988; 38: 143-9.
34. SHECKTER CB, MATSUMOTO AM, BREMMER WJ. Testosterone administration inhibition inhibits gonadotropin secretion by an effect direct by on the human pituitary. J Clin Endocrinol Metab 1989; 68: 397-401.
35. GIGUERE V, LEFEBVRE FA, LABRIE F. Androgens decrease LHRH binding sites in rat anterior pituitary cells in culture. Endocrinology 1981; 108: 350-2.
36. DROUIN J, LAVOIE M, LABRIE F. Effect of gonadal steroids on the luteinising hormone follicle stimulating hormone response to 8-bromo-adenosine-3′, 5′-monophosphate in anterior pituitary cells in culture. Endocrinology 1978; 102: 358-64.
37. COUZINET B, SCHAISON G. The control of gonadotrophin secretion by ovarian steroids. Human Reproduction 1993; 8 (Suppl 2): 97-101.
38. GOH HH, RATNAM S S. The gonadotrophin surge in humans: Its mechanism and role in ovulatory function-A review. Ann Acad Med 1990; 19: 524-9.
39. SERAFINI P, SILVA PD, PAULSON RJ, ELKIND-HIRSCH K, HERNANDEZ M, LOBO RA. Acute modulation of the hypothalamic-pituitary axis by intravenous testosterone in normal women. Am J Obstet Gynecol 1986; 155: 1288-92.
40. SPINDER T, SPIJKSTRA JJ, GOOREN LJG, HOMPES PGA, VAN KESSEL H. Effects of long-term testosterone administration on gonadotropin secretion in agonadal female to male transsexuals compared with hypogonadal and normal women. J Clin Endocrinol Metab 1989; 68: 200-7.
41. DUNAIF A, SCULLY RE, ANDERSEN RN, ET AL. The effects of continuous androgen secretion on the hypothalamic-pituitary axis in woman: Evidence from a luteinized thecoma of the ovary. J Chin Endocrinol Metab 1984; 59: 389-93.
42. DEVOTO L, SIR T, IZQUIERDO C, ALBA F, FUENTES A. Efecto de la resección microquirúrgica del ovario en la fertilidad de pacientes con ovario poliquístico resistente al Citrato de Clomifeno. Rev Chil Obstet Ginecol 1991; LVI (2): 94-8.
43. SIR-PETERMANN T, RABENBAUER B, WILDT L. The effect of flutamide on pulsatile gonadotrophin secretion in hyperandrogenaemic women. Human Reproduction 1993; 8: 1807-12.
44. SIR-PETERMANN T, ALBA F, TRONCOSO J, MUÑOZ A, CIPRIANO A, CANDIA M, DEVOTO L. Effect of chronic androgen receptor blockade on gonadotropin secretion and follicular development in hiperandrogenic women. In: Ovulation Induction: Basic science and clinical advances (Abstracts). January 20-22, 1994. Palm Beach, Florida, USA.
45. SIR-PETERMANN T, MUÑOZ A, CANDIA M, ALBA F, TRONCOSO J, DEVOTO L. LH secretion by the female pituitary: effect of testosterone and the blockade of its receptor. Experimental and Clinical Endocrinology & Diabetes 1996; 104 (Suppl 1): 20.